These HR/NHEJ kits are cell based, meaning they have the HR or NHEJ GFP reporters pre-installed. A single plasmid (I-Sce1) is transfected to activate repair. Please see this table for a summary and comparison/application of each kit.
Homologous GFP Repair Systems
HeLa Cell HR Kit (I-Sce1 Based)
HeLa Cell HR Kit (CRISPR-CAS Based)
Human Neuroblastoma Cell Line SH-SY5Y using (I-Sce1 transfection)
Mouse 3T3 Cell Line using I-Sce1 transfection
Mouse Neuronal Cell Line using I-Sce1 transfection
Custom construction Kit to make your own HR Cell Reporter
NHEJ GFP Reporter
Systems
Transfection-based HR and NHEJ kits use transient transfections to make a pool of cells containing the DNA reporters to allow the investigator to interrogate the 2 major DNA repair pathways. The advantages are:
-ALL OF OUR PRODUCTS ARE VALIDATED & CERTIFIED BY TOPOGEN SCIENTISTS-
Product ID | Product Info | Description | Purchase |
---|---|---|---|
TG2001GKIT |
This kit is designed to screen for novel gyrase targeting drugs, either as interfacial poisons (or IFPs that induce cleavage of DNA) Catalytic inhibitory compounds (CICs that block gyrase action by any number of mechanisms). It is a straight forward gel assay kit that is easily adopted. This kit contains purified bacterial (E. coli) DNA Gyrase purified to homogeneity (>98% based on SDS-PAGE), as well as substrate relaxed DNA (plasmid pHOT1).
Read more | Max: Min: 1 Step: 1 Add to Cart | |
TG1007 |
The Topoisomerase IV Drug Screening Kit contains reagents necessary to identify compounds that affect enzyme activity. Note that kits with a catalog number denoted -A will include E. coli topoisomerase IV enyzme.
Read more | Max: Min: 1 Step: 1 Add to Cart | |
TG1018 |
The Topo I Drug Kit is designed to allow the investigator to quickly identify novel inhibitors of Human Top1. It will allow detection of novel compounds that either stabilize the nicked intermediate or otherwise inhibit catalytic activity of topoisomerase I. This kit is ideal for pharmaceutical researchers, academic scientists, and biotech professionals seeking to develop and characterize new therapeutic agents targeting Topoisomerase I.
Your browser does not support the video tag.
Read more | Max: Min: 1 Step: 1 Add to Cart | |
TG1017 | This kit is designed to allow the customer to screen for agents (drugs, natural products, small molecules, synthetics) that block the catalytic activity of human topoisomerase I (topo I). The use of high stoichiometric ratios of topo I:DNA induces cleavage complexes without the need to use topo I poisons (camptothecin) which facilitates detection of catalytic inhibitors of topoI. The assay (see ref 1) is based on the finding that topo I acts in a cooperative manner on DNA template, whereby it tends to display clustered activity (at neighboring sites, see ref 3); thus, at high ratios of enzyme:DNA, it is… Read more | Max: Min: 1 Step: 1 Add to Cart | |
TG1009 |
This is a cleavage based detection kit that will reveal whether a particular agent either antagonizes the action of topo II or affects the cleavage/religation cycle. Reactions are assembled in microcentrifuge tubes using reagents supplied in the kit (buffer, DNA, control inhibitor).
Read more | Max: Min: 1 Step: 1 Add to Cart | |
TG1019 | This kDNA based Topo II Drug Screening Kit is designed to identify agents that target type II topoisomerases acting as catalytic inhibitors, primarily; however, poisons can also be detected with this kit. Read more | Max: Min: 1 Step: 1 Add to Cart |
WHY CHOOSE US
When you become our customer, we become your partner in research. We review your data and offer valuable input. Feel free to contact us for further information about how we can assist your topoisomerase research endeavors.